Table 3.

Changes in the questionnaire scores between baseline and at 6 months depending on the type of oral anticoagulant treatment.

	VKA					NOAC
	Baseline	6 months	Difference	p		Baseline	6 months	Difference	p
General treatment satisfaction	2.5 ± 1.0	2.3 ± 1.0	-0.2	< 0.01		2.4 ± 1.2	2.2 ± 1.0	-0.2	0.48
Distress	3.3 ± 1.1	3.1 ± 1.0	-0.2	< 0.001		3.3 ± 1.1	3.1 ± 0.9	-0.2	0.24
Daily hassles	2.3 ± 1.1	2.1 ± 1.0	-0.2	< 0.005		2.2 ± 1.1	2.0 ± 0.9	-0.2	0.45
Strained social network	2.1 ± 1.0	1.9 ± 0.9	-0.2	< 0.05		1.9 ± 2.0	2.0 ± 0.8	0.1	0.43

VKA, vitamin K antagonists; NOAC, new oral anticoagulant.